{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T16:47:23Z","timestamp":1781196443506,"version":"3.54.1"},"reference-count":67,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.eimc.2013.03.016","type":"journal-article","created":{"date-parts":[[2013,5,17]],"date-time":"2013-05-17T10:30:33Z","timestamp":1368786633000},"page":"402-409","source":"Crossref","is-referenced-by-count":39,"title":["Infecciones causadas por bacterias gramnegativas multirresistentes: enterobacterias, Pseudomonas aeruginosa, Acinetobacter baumannii y otros bacilos gramnegativos no fermentadores"],"prefix":"10.1016","volume":"31","author":[{"given":"Mar\u00eda Carmen","family":"Fari\u00f1as","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Mart\u00ednez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.eimc.2013.03.016_bib0005","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0213-005X(10)70027-6","article-title":"The growing problem of antibiotic resistance in clinically relevant Gram-negative bacteria: Current situation","volume":"28","author":"Mart\u00ednez-Mart\u00ednez","year":"2010","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2013.03.016_bib0010","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1574-6976.2011.00268.x","article-title":"Multiresistant Gram-negative bacteria: The role of high-risk clones in the dissemination of antibiotic resistance","volume":"35","author":"Woodford","year":"2011","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.eimc.2013.03.016_bib0015","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/QCO.0b013e32833f0d3e","article-title":"Multiresistant Gram-negative infections: A global perspective","volume":"23","author":"Ho","year":"2010","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.eimc.2013.03.016_bib0020","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1476-5381.2011.01250.x","article-title":"Novel classes of antibiotics or more of the same","volume":"163","author":"Coates","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"Suppl 1","key":"10.1016\/j.eimc.2013.03.016_bib0025","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1086\/655988","article-title":"The antibiotic development pipeline for multidrug-resistant gram-negative bacilli: Current and future landscapes","volume":"31","author":"Talbot","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.eimc.2013.03.016_bib0030","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimc.2013.03.016_bib0035","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.eimc.2010.05.002","article-title":"Interpretive reading of enterobacteria antibiograms","volume":"28","author":"Navarro","year":"2010","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"Suppl 5","key":"10.1016\/j.eimc.2013.03.016_bib0040","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1469-0691.2007.01860.x","article-title":"ESBL and permeability barrier","volume":"13","author":"Mart\u00ednez-Mart\u00ednez","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimc.2013.03.016_bib0045","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0140-6736(97)07322-4","article-title":"Quinolone resistance from a transferable plasmid","volume":"351","author":"Mart\u00ednez-Mart\u00ednez","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.eimc.2013.03.016_bib0050","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1128\/JCM.00219-10","article-title":"Extended-spectrum-beta-lactamase, AmpC, and carbapenemase issues","volume":"48","author":"Thomson","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2013.03.016_bib0055","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","article-title":"Extended-spectrum beta-lactamases: A clinical update","volume":"18","author":"Paterson","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.eimc.2013.03.016_bib0060","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1586\/14787210.6.5.671","article-title":"Clinical significance of extended spectrum beta-lactamases","volume":"6","author":"Rodr\u00edguez-Ba\u00f1o","year":"2008","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.eimc.2013.03.016_bib0065","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.3201\/eid0908.030094","article-title":"Community transmission of extended-spectrum B-lactamase","volume":"9","author":"Mirellis","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.eimc.2013.03.016_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1157\/13070400","article-title":"Involvement of bacterial resistances in community-acquired urinary infections","volume":"23","author":"Horcajada","year":"2005","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2013.03.016_bib0075","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1128\/JCM.40.4.1237-1243.2002","article-title":"Epidemiology of extended-spectrum beta-lactamase-producing Enterobacter isolates in a Spanish hospital during a 12-year period","volume":"40","author":"Cant\u00f3n","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2013.03.016_bib0080","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1157\/13042863","article-title":"Escherichia coli y Klebsiella pneumoniae productores de beta-lactamasas de espectro extendido en hospitales espa\u00f1oles (Proyecto GEIH-BLEE 2000)","volume":"21","author":"Hern\u00e1ndez","year":"2003","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2013.03.016_bib0085","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1128\/AAC.49.5.2122-2125.2005","article-title":"Escherichia coli and Klebsiella pneumoniae producing extended-spectrum beta-lactamases in Spain: A nationwide study","volume":"49","author":"Hern\u00e1ndez","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2013.03.016_bib0090","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1128\/JCM.42.10.4769-4775.2004","article-title":"Dramatic increase in prevalence of fecal carriage of extended-spectrum betalactamase-producing Enterobacteriaceae during non-outbreak situations in Spain","volume":"42","author":"Valverde","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2013.03.016_bib0095","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1001\/archinte.168.17.1897","article-title":"Community infections caused by extended-spectrum \u03b2-lactamase-producing Escherichia coli","volume":"168","author":"Rodr\u00edguez-Ba\u00f1o","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.eimc.2013.03.016_bib0100","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1128\/JCM.02147-09","article-title":"Diversity of Escherichia coli strains producing extended-spectrum beta-lactamases in Spain: Second nationwide study","volume":"48","author":"D\u00edaz","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2013.03.016_bib0105","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1128\/JCM.02514-10","article-title":"Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases in Spain: Microbiological and clinical features","volume":"49","author":"Ruiz de Alegr\u00eda","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2013.03.016_bib0110","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1093\/jac\/dkr235","article-title":"National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain","volume":"66","author":"Blanco","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2013.03.016_bib0115","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/jac\/dkq491","article-title":"Spread of Escherichia coli O25b:H4-B2-ST131 producing CTX-M-15 and SHV-12 with high virulence gene content in Barcelona (Spain)","volume":"66","author":"Coelho","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2013.03.016_bib0340","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.eimc.2012.09.005","article-title":"Escherichia coli O25b:H4\/ST131 are prevalent in Spain and are often not associated with ESBL or quinolone resistance","volume":"31","author":"L\u00f3pez-Cerero","year":"2013","journal-title":"Enferm Infecc Microbiol Clin."},{"key":"10.1016\/j.eimc.2013.03.016_bib0125","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1128\/JCM.42.3.1089-1094.2004","article-title":"Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients","volume":"42","author":"Rodr\u00edguez-Ba\u00f1o","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2013.03.016_bib0130","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1128\/JCM.02353-09","article-title":"Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli","volume":"48","author":"Rodr\u00edguez-Ba\u00f1o","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2013.03.016_bib0135","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1086\/604713","article-title":"A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients","volume":"49","author":"Ben-Ami","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2013.03.016_bib0140","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/1471-2334-12-245","article-title":"Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study","volume":"12","author":"Peralta","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.eimc.2013.03.016_bib0145","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1128\/CMR.00036-08","article-title":"AmpC beta-lactamases","volume":"22","author":"Jacoby","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.eimc.2013.03.016_bib0150","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10096-012-1737-0","article-title":"Prevalence and molecular epidemiology of acquired AmpC \u03b2-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain","volume":"32","author":"Mir\u00f3","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.eimc.2013.03.016_bib0155","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jinf.2011.11.016","article-title":"Colonisation and infection due to Enterobacteriaceae producing plasmid-mediated AmpC \u03b2-lactamases","volume":"64","author":"Rodr\u00edguez-Ba\u00f1o","year":"2012","journal-title":"J Infect"},{"key":"10.1016\/j.eimc.2013.03.016_bib0160","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1469-0691.2012.03821.x","article-title":"Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe","volume":"18","author":"Cant\u00f3n","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimc.2013.03.016_bib0165","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1469-0691.2009.03116.x","article-title":"Acquired carbapenemases in Gram-negative bacterial pathogens: Detection and surveillance issues","volume":"16","author":"Miriagou","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimc.2013.03.016_bib0170","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/jac\/dks364","article-title":"Infections caused by OXA-48-producing Klebsiella pneumoniae in a tertiary hospital in Spain in the setting of a prolonged, hospital-wide outbreak","volume":"68","author":"Pa\u00f1o-Pardo","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2013.03.016_bib0175","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1128\/AAC.00329-11","article-title":"First outbreak of a plasmid-mediated carbapenem-hydrolyzing OXA-48 beta-lactamase in Klebsiella pneumoniae in Spain","volume":"55","author":"Pitart","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2013.03.016_bib0180","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/j.1469-0691.2011.03673.x","article-title":"Impact of changes in CLSI and EUCAST breakpoints for susceptibility in bloodstream infections due to extended-spectrum \u03b2-lactamase-producing Escherichia coli","volume":"18","author":"Rodr\u00edguez-Ba\u00f1o","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimc.2013.03.016_bib0185","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1086\/380645","article-title":"Bacteremia due to Klebsiella pneumoniae isolates producing the TEM-52 extended-spectrum beta-lactamase treatment outcome of patients receiving imipenem or ciprofloxacin","volume":"38","author":"Endimiani","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2013.03.016_bib0190","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/cid\/cir790","article-title":"\u03b2-Lactam\/\u03b2-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum \u03b2-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts","volume":"54","author":"Rodr\u00edguez-Ba\u00f1o","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2013.03.016_bib0195","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.1128\/AAC.48.12.4574-4581.2004","article-title":"Bloodstream infections due to extended spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: Risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy","volume":"48","author":"Kang","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2013.03.016_bib0200","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jhin.2009.04.020","article-title":"Pseudomonas aeruginosa: a formidable and ever-present adversary","volume":"73","author":"Kerr","year":"2009","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.eimc.2013.03.016_bib0205","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2147\/IDR.S16263","article-title":"Management of refractory Pseudomonas aeruginosa infection in cystic fibrosis","volume":"4","author":"Sord\u00e9","year":"2011","journal-title":"Infec Drug Resist"},{"key":"10.1016\/j.eimc.2013.03.016_bib0210","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.eimc.2010.05.001","article-title":"Interpretive reading of the non-fermenting gram-negative bacilli antibiogram","volume":"28","author":"Vila","year":"2010","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2013.03.016_bib0215","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1128\/CMR.00040-09","article-title":"Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms","volume":"22","author":"Lister","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.eimc.2013.03.016_bib0220","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ijmm.2011.10.001","article-title":"Structure and function of OprD protein in Pseudomonas aeruginosa: from antibiotic resistance to novel therapies","volume":"302","author":"Li","year":"2012","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.eimc.2013.03.016_bib0225","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1128\/AAC.01645-10","article-title":"Overexpression of AmpC and efflux pumps in P.aeruginosa from blood stream infections: Prevalence and linkage to resistance in a Spanish multicenter study","volume":"55","author":"Cabot","year":"2011","journal-title":"Antimibrob Agents Chemother"},{"key":"10.1016\/j.eimc.2013.03.016_bib0230","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1128\/AAC.00810-07","article-title":"Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals","volume":"51","author":"Guti\u00e9rrez","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2013.03.016_bib0235","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1128\/AAC.05451-11","article-title":"Alterations of OprD in carbapenem-intermediate and -susceptible strains of Pseudomonas aeruginosa isolated from patients with bacteremia in a Spanish multicenter study","volume":"56","author":"Ocampo-Sosa","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2013.03.016_bib0240","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.eimc.2009.01.013","article-title":"Molecular characterization of Pseudomonas aeruginosa isolates in Cantabria, Spain, producing VIM-2 metallo-beta-lactamase","volume":"28","author":"Rodr\u00edguez","year":"2010","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2013.03.016_bib0245","doi-asserted-by":"crossref","first-page":"6349","DOI":"10.1128\/AAC.01388-12","article-title":"Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones","volume":"56","author":"Cabot","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2013.03.016_bib0250","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.eimc.2008.09.009","article-title":"Nosocomial outbreak by imipenem-resistant Pseudomonas aeruginosa producing metallo-b-lactamase in adults intensive care unit in a Brazilian teaching hospital","volume":"27","author":"Cezario","year":"2009","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2013.03.016_bib0255","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1128\/AAC.05991-11","article-title":"Prospective multicenter study of the impact of carbapenem resistance on mortality in Pseudomonas aeruginosa bloodstream infections","volume":"56","author":"Pe\u00f1a","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2013.03.016_bib0260","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1473-3099(06)70580-1","article-title":"Colistin: The re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections","volume":"6","author":"Li","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.eimc.2013.03.016_bib0265","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1128\/MMBR.20.1.14-27.1956","article-title":"The properties and mode of action of the polymyxins","volume":"20","author":"Newton","year":"1956","journal-title":"Bacteriol Rev"},{"key":"10.1016\/j.eimc.2013.03.016_bib0270","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3121\/cmr.4.2.138","article-title":"The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: A review of the recent literature","volume":"4","author":"Falagas","year":"2006","journal-title":"Clin Med Res"},{"key":"10.1016\/j.eimc.2013.03.016_bib0275","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/AAC.47.9.2756-2764.2003","article-title":"Effectiveness of combination antimicrobial therapy for Pseudomonas aeruginosa bacteremia","volume":"47","author":"Chamot","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2013.03.016_bib0280","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/cit223","article-title":"Effect of adequate single-drug versus combination antimicrobial therapy on mortality in Pseudomonas aeruginosa bloodstream infections. A post hoc analysis of a prospective cohort","author":"Pe\u00f1a","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2013.03.016_bib0285","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3389\/fmicb.2012.00148","article-title":"The Acinetobacter baumannii oxymoron: Commensal hospital dweller turned pan-drug-resistant menace","volume":"3","author":"Roca","year":"2012","journal-title":"Front Microbiol"},{"key":"10.1016\/j.eimc.2013.03.016_bib0290","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1469-0691.2011.03696.x","article-title":"Rapid and accurate identification of genomic species from the Acinetobacter baumannii group by MALDI-TOF MS","volume":"18","author":"Espinal","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimc.2013.03.016_bib0295","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0213-005X(04)73085-2","article-title":"Clonal diversity and antimicrobial susceptibility of Acinetobacter baumannii isolated in Spain. A nationwide multicenter study: GEIH-Ab project (2000)","volume":"22","author":"Fern\u00e1ndez-Cuenca","year":"2004","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2013.03.016_bib0300","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.eimc.2012.06.010","article-title":"Actividad de 18 agentes antimicrobianos frente a aislados cl\u00ednicos de Acinetobacter baumannii: segundo estudio nacional multic\u00e9ntrico (proyecto GEIH-REIPI-Ab 2010)","volume":"31","author":"Fern\u00e1ndez-Cuenca","year":"2013","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2013.03.016_bib0305","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1086\/502302","article-title":"Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitals (GEIH.Ab 2000 project)","volume":"25","author":"Rodr\u00edguez-Ba\u00f1o","year":"2004","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.eimc.2013.03.016_bib0310","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.1469-0691.2005.01256.x","article-title":"Risk factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain. A nationwide study","volume":"11","author":"Cisneros","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimc.2013.03.016_bib0315","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1517\/14656566.2012.729820","article-title":"Therapeutic options for Acinetobacter baumannii infections: An update","volume":"13","author":"Vila","year":"2012","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.eimc.2013.03.016_bib0320","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s00701-009-0382-6","article-title":"Multidrug-resistant Acinetobacter baumannii ventriculitis: Successful treatment with intraventricular colistin","volume":"151","author":"L\u00f3pez-Alvarez","year":"2009","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.eimc.2013.03.016_bib0325","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1586\/eri.11.24","article-title":"Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment","volume":"9","author":"Abbott","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.eimc.2013.03.016_bib0330","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.2217\/fmb.09.84","article-title":"Attributable mortality of Stenotrophomonas maltophilia infections: A systematic review of the literature","volume":"4","author":"Falagas","year":"2009","journal-title":"Future Microbiol"},{"key":"10.1016\/j.eimc.2013.03.016_bib0335","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/jac\/dkn301","article-title":"Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: A systematic review","volume":"62","author":"Falagas","year":"2008","journal-title":"J Antimicrob Chemother"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X13000955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X13000955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T14:00:55Z","timestamp":1584021655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X13000955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":67,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0213005X13000955"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2013.03.016","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}